Breslow Thickness, Clark Index and Ulceration Are Associated with Sentinel Lymph Node Metastasis in Melanoma Patients: A Cohort Analysis of 612 Patients
Authors:
- Valérie Lauwers-CancesVLValérie Lauwers-Cances
- Laurence LamantLLLaurence Lamant
- Catherine GentilCGCatherine Gentil
- Philippe RochaixPRPhilippe Rochaix
- Ignacio GarridoIGIgnacio Garrido
- Raphael LopezRLRaphael Lopez
- Christine ChevreauCCChristine Chevreau
- Carle PaulCPCarle Paul
- Nicolas MeyerNMNicolas Meyer
- 26 August 2014
- journal article
- research article
- Published by S. Karger AG in Dermatology
- Vol. 229 (3) , 183-189
Abstract
Background: Sentinel lymph node biopsy (SLNB) is the most sensitive procedure for assessing nodal status in patients with primary melanoma. Objective: To evaluate the predictive ability of usual primary melanoma prognosis factors of detecting sentinel lymph node (SLN) metastasis in patients with melanoma. Patients and Methods: A cohort of 612 consecutive patients presenting with primary skin melanoma who underwent a SLNB was evaluated. Assessment of the determinants of SLN metastasis was based on general linear model analysis. The model performance was studied using the concordance statistic and the net reclassification index. The calibration was estimated using the Hosmer-Lemeshow test. Results: The discrimination ability did not differ significantly between Breslow thickness (0.57), Clark index (0.61), ulceration (0.57) and histological subtype (0.55). Clark index, ulceration and Breslow thickness were all significant and independent determinants of SLN metastasis. The predictive ability of the final model was 0.657. Conclusion: Breslow thickness, Clark index and ulceration are independent predictors of a SLN metastasis.Keywords
This publication has 39 references indexed in Scilit:
- Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thickerThe American Journal of Surgery, 2011
- Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging DatabaseJournal of Clinical Oncology, 2011
- The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I)Annals of Surgical Oncology, 2010
- Sentinel lymph node biopsy and melanoma: 2010 updateJournal of the American Academy of Dermatology, 2010
- Sentinel lymph node biopsy and melanoma: 2010 updateJournal of the American Academy of Dermatology, 2010
- Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?Cancer, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- High positive sentinel node identification rate by EORTC melanoma group protocolEuropean Journal of Cancer, 2006
- Thin #1 mm Level III and IV Melanomas Are Higher Risk Lesions For Regional Failure and Warrant Sentinel Lymph Node BiopsyAnnals of Surgical Oncology, 2000
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992